Factors influencing adverse events following COVID-19 vaccination

References

• World Health Organization. Coronavirus disease (COVID-19) pandemic. 2023 [accessed 2023 May 25]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
   Google Scholar
• World Health Organization. COVID-19 vaccine tracker. 2022 Dec 2 [accessed 2023 Aug 28]. https://covid19.trackvaccines.org/agency/who/.
   Google Scholar
• Mathieu E, Ritchie H, Rodés-Guirao L, Appel C, Giattino C, Hasell J, Macdonald B, Dattani S, Beltekian D, O-O E. et al. Our world in data: coronavirus (COVID-19) vaccinations. 2023 [accessed 2023 Aug 28]. https://ourworldindata.org/coronavirus.
   Google Scholar
• Lazarus JV, Wyka K, White TM, Picchio CA, Rabin K, Ratzan SC, Parsons Leigh J, Hu J, El-Mohandes A. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nat Commun. 2022;13(1):3801. doi:10.1038/s41467-022-31441-x.
   PubMed Web of Science ®Google Scholar
• Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245–10. doi:10.1016/j.puhe.2021.02.025.
   PubMed Web of Science ®Google Scholar
• Azarpanah H, Farhadloo M, Vahidov R, Pilote L. Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases. BMC Public Health. 2021;21(1):1686. doi:10.1186/s12889-021-11745-1.
   PubMed Web of Science ®Google Scholar
• Australian Government. Australian technical advisory group on immunisation. [accessed 2023 May 24]. https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi.
   Google Scholar
• World Health Organization. The Sinovac-CoronaVac COVID-19 vaccine: what you need to know. 2022 [accessed 2023 May 24]. https://www.who.int/news-room/feature-stories/detail/the-sinovac-covid-19-vaccine-what-you-need-to-know.
   Google Scholar
• Pittet LF, Messina NL, Gardiner K, Orsini F, Abruzzo V, Bannister S, Bonten M, Campbell JL, Croda J, Dalcolmo M. et al. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: protocol for a randomised controlled trial (BRACE trial). BMJ Open. 2021;11(10):e052101. doi:10.1136/bmjopen-2021-052101.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81. doi:10.1016/j.jbi.2008.08.010.
   PubMed Web of Science ®Google Scholar
• Messina NL, Sperotto MG, Puga MAM, da Silva PV, de Oliveira RD, Moore CL, Pittet LF, Jamieson T, Dalcolmo M, Dos Santos G. et al. Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination. Front Immunol. 2023;14:1172851. doi:10.3389/fimmu.2023.1172851.
   PubMedGoogle Scholar
• Bond KA, Williams E, Nicholson S, Lim S, Johnson D, Cox B, Putland M, Gardiner E, Tippett E, Graham M. et al. Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection. Pathology. 2021;53(6):773–779. doi:10.1016/j.pathol.2021.05.093.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Guidance for industry: toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. 2007.
   Google Scholar
• Alqahtani S, Jokhdar H, Al-Tawfiq JA, Al-Otaibi S, Assiri A, Almudarra S, Alabdulkareem K, Haji A. Adverse events following administration of COVID-19 vaccines in Saudi Arabia. Sci Rep. 2022;12:19551. doi:10.1038/s41598-022-23471-8.
   PubMed Web of Science ®Google Scholar
• Chapin-Bardales J, Gee J, Myers T. Reactogenicity following receipt of mRNA-based COVID-19 vaccines. JAMA. 2021;325(21):2201–2202. doi:10.1001/jama.2021.5374.
   PubMed Web of Science ®Google Scholar
• Graña C, Ghosn L, Evrenoglou T, Jarde A, Minozzi S, Bergman H, Buckley BS, Probyn K, Villanueva G, Henschke N. et al. Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev. 2022;12:Cd015477. doi:10.1002/14651858.CD015477.
   PubMedGoogle Scholar
• Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt HP, Attia S. Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers. Biology (Basel). 2021;10(8):752. doi:10.3390/biology10080752.
   PubMedGoogle Scholar
• Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, Sudre CH, Nguyen LH, Drew DA, Merino J. et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939–949. doi:10.1016/S1473-3099(21)00224-3.
   PubMed Web of Science ®Google Scholar
• Orebi HA, Emara HE, Alhindi AA, Shahin MR, Hegazy AH, Kabbash IA, Saied SM. Perceptions and experiences of COVID-19 vaccines’ side effects among healthcare workers at an Egyptian university hospital: a cross-sectional study. Trop Med Health. 2022;50(1):37. doi:10.1186/s41182-022-00427-2.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W. et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21:181–92. doi:10.1016/S1473-3099(20)30843-4.
   PubMed Web of Science ®Google Scholar
• Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA. et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467–478. doi:10.1016/S0140-6736(20)31604-4.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Amaro C, Monteiro C, Duarte AP. COVID-19 vaccines adverse reactions reported to the pharmacovigilance unit of Beira interior in portugal. J Clin Med. 2022;11(19):5591. doi:10.3390/jcm11195591.
   PubMed Web of Science ®Google Scholar
• Paczkowska A, Hoffmann K, Michalak M, Hans-Wytrychowska A, Bryl W, Kopciuch D, Zaprutko T, Ratajczak P, Nowakowska E, Kus K. Safety profile of COVID-19 vaccines among healthcare workers in Poland. Vaccines. 2022;10(3):434. doi:10.3390/vaccines10030434.
   Web of Science ®Google Scholar
• Ryan FJ, Norton TS, McCafferty C, Blake SJ, Stevens NE, James J, Eden GL, Tee YC, Benson SC, Masavuli MG. et al. A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines. Cell Rep Med. 2023;4(3):100971. doi:10.1016/j.xcrm.2023.100971.
   PubMedGoogle Scholar
• Peacock S, Patel S. Cultural influences on pain. Rev Pain. 2008;1(2):6–9. doi:10.1177/204946370800100203.
   PubMedGoogle Scholar
• Rupe A, Ahlers-Schmidt CR, Wittler R. A comparison of perceptions of fever and fever phobia by ethnicity. Clin Pediatr (Phila). 2009;49:172–6. doi:10.1177/0009922809336208.
   PubMed Web of Science ®Google Scholar
• Mayr FB, Spiel AO, Leitner JM, Firbas C, Kliegel T, Jilma B. Ethnic differences in plasma levels of interleukin-8 (IL-8) and granulocyte colony stimulating factor (G-CSF). Transl Res. 2007;149(1):10–14. doi:10.1016/j.trsl.2006.06.003.
   PubMed Web of Science ®Google Scholar
• Delaney NL, Esquenazi V, Lucas DP, Zachary AA, Leffell MS. TNF-alpha, TGF-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI minority workshops: part IV. Hum Immunol. 2004;65:1413–19. doi:10.1016/j.humimm.2004.07.240.
   PubMed Web of Science ®Google Scholar
• Gebru AA, Birhanu T, Wendimu E, Ayalew AF, Mulat S, Abasimel HZ, Kazemi A, Tadesse BA, Gebru BA, Deriba BS. et al. Global burden of COVID-19: situational analyis and review. Hum Antibodies. 2021;29(2):139–148. doi:10.3233/HAB-200420.
   PubMedGoogle Scholar
• Bigoni A, Malik AM, Tasca R, Carrera MBM, Schiesari LMC, Gambardella DD, Massuda A. Brazil’s health system functionality amidst of the COVID-19 pandemic: an analysis of resilience. Lancet Reg Health – Am. 2022;10:100222. doi:10.1016/j.lana.2022.100222.
   PubMedGoogle Scholar
• Sato TO, de Faria BSF, Albuquerque BB, Silva FLD, Rohwedder LS, de Azevedo RT, Gonçalves JS, Vieira L, Triches MI, de Sousa RA. et al. Poor health conditions among Brazilian healthcare workers: the study design and baseline characteristics of the HEROES cohort. Healthcare (Basel). 2022;10:2096. doi:10.3390/healthcare10102096.
   PubMedGoogle Scholar
• Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130(4):601–630. doi:10.1037/0033-2909.130.4.601.
   PubMed Web of Science ®Google Scholar
• Marsland AL, Walsh C, Lockwood K, John-Henderson NA. The effects of acute psychological stress on circulating and stimulated inflammatory markers: a systematic review and meta-analysis. Brain Behav Immun. 2017;64:208–219. doi:10.1016/j.bbi.2017.01.011.
   PubMed Web of Science ®Google Scholar
• Alexis JP, Catherine G, Peter J, Helen EQ, Parveen F, Patrick C, Alan L, Christopher CB, Michael SG, Thomas S. et al. Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia. BMJ Open. 2018;8:e023263. doi:10.1136/bmjopen-2018-023263.
   PubMed Web of Science ®Google Scholar
• Smetana J, Chlibek R, Shaw J, Splino M, Prymula R. Influenza vaccination in the elderly. Hum Vaccin Immunother. 2018;14:540–9. doi:10.1080/21645515.2017.1343226.
   PubMed Web of Science ®Google Scholar
• Govaert TM, Dinant GJ, Aretz K, Masurel N, Sprenger MJ, Knottnerus JA. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ. 1993;307(6910):988–990. doi:10.1136/bmj.307.6910.988.
   PubMed Web of Science ®Google Scholar
• Warkentin L, Werner F, Zeschick N, Kühlein T, Steininger P, Überla K, Kaiser I, Sebastião M, Hueber S. Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens: a comparative observational cohort study. BMC Med. 2023;21:218. doi:10.1186/s12916-023-02924-5.
   PubMed Web of Science ®Google Scholar
• Mathioudakis AG, Ghrew M, Ustianowski A, Ahmad S, Borrow R, Papavasileiou LP, Petrakis D, Bakerly ND. Self-reported real-world safety and reactogenicity of COVID-19 vaccines: a vaccine recipient survey. Life (Basel). 2021;11(3):249. doi:10.3390/life11030249.
   Web of Science ®Google Scholar
• Rolfes L, Härmark L, Kant A, van Balveren L, Hilgersom W, van Hunsel F. COVID-19 vaccine reactogenicity - a cohort event monitoring study in the Netherlands using patient reported outcomes. Vaccine. 2022;40:970–6. doi:10.1016/j.vaccine.2022.01.013.
   PubMed Web of Science ®Google Scholar
• Müller L, Andrée M, Moskorz W, Drexler I, Walotka L, Grothmann R, Ptok J, Hillebrandt J, Ritchie A, Rabl D. et al. Age-dependent immune response to the biontech/Pfizer BNT162b2 coronavirus disease 2019 vaccination. Clin Infect Dis. 2021;73(11):2065–2072. doi:10.1093/cid/ciab381.
   PubMed Web of Science ®Google Scholar
• Crooke SN, Ovsyannikova IG, Poland GA, Kennedy RB. Immunosenescence and human vaccine immune responses. Immun Ageing. 2019;16:25. doi:10.1186/s12979-019-0164-9.
   PubMed Web of Science ®Google Scholar
• El Yousfi M, Mercier S, Breuillé D, Denis P, Papet I, Mirand PP, Obled C. The inflammatory response to vaccination is altered in the elderly. Mech Ageing Dev. 2005;126(8):874–881. doi:10.1016/j.mad.2005.03.008.
   PubMed Web of Science ®Google Scholar
• Hervé C, Laupèze B, Del Giudice G, Didierlaurent AM, Tavares Da Silva F. The how’s and what’s of vaccine reactogenicity. NPJ Vaccines. 2019;4:39. doi:10.1038/s41541-019-0132-6.
   PubMed Web of Science ®Google Scholar
• Das RR, Panigrahi I, Naik SS, Quach C. The effect of prophylactic antipyretic administration on post-vaccination adverse reactions and antibody response in children: a systematic review. PloS One. 2014;9(9):e106629. doi:10.1371/journal.pone.0106629.
   PubMed Web of Science ®Google Scholar
• Zhuang C-L, Lin Z-J, Bi Z-F, Qiu L-X, Hu F-F, Liu X-H, Lin B-Z, Su Y-Y, Pan H-R, Zhang T-Y. et al. Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response. Emerging Microbes Infect. 2021;10(1):365–375. doi:10.1080/22221751.2021.1891002.
   PubMed Web of Science ®Google Scholar
• Peikert A, Claggett BL, Kim K, Udell JA, Joseph J, Desai AS, Farkouh ME, Hegde SM, Hernandez AF, Bhatt DL. et al. Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial. Eur J Heart Fail. 2023;25(2):299–310. doi:10.1002/ejhf.2716.
   PubMed Web of Science ®Google Scholar
• Uwamino Y, Kurafuji T, Sato Y, Tomita Y, Shibata A, Tanabe A, Yatabe Y, Noguchi M, Arai T, Ohno A. et al. Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: an observational study of 646 Japanese healthcare workers and university staff. Vaccine. 2022;40(7):1019–1025. doi:10.1016/j.vaccine.2022.01.002.
   PubMed Web of Science ®Google Scholar
• Jubishi D, Okamoto K, Hamada K, Ishii T, Hashimoto H, Shinohara T, Yamashita M, Wakimoto Y, Otani A, Hisasue N. et al. The association between adverse reactions and immune response against SARS-CoV-2 spike protein after vaccination with BNT162b2 among healthcare workers in a single healthcare system: a prospective observational cohort study. Hum Vaccin Immunother. 2022;18:2048559. doi:10.1080/21645515.2022.2048559.
   PubMed Web of Science ®Google Scholar
• Debes AK, Xiao S, Colantuoni E, Egbert ER, Caturegli P, Gadala A, Milstone AM. Association of vaccine type and prior SARS-CoV-2 infection with symptoms and antibody measurements following vaccination among health care workers. JAMA Intern Med. 2021;181(12):1660–1662. doi:10.1001/jamainternmed.2021.4580.
   PubMed Web of Science ®Google Scholar
• Bannister WP, Raben D, Valentiner-Branth P, Tolstrup M, Larsen L, Tarp B, Brouw Iversen M, Schmeltz Søgaard O, Rye Ostrowski S, Breinholt Stærke N. et al. Association of self-reported systemic reactions following SARS-CoV-2 vaccination with immunological response in the Danish national cohort study of effectiveness and safety of SARS-CoV-2 vaccines (ENFORCE). Open Forum Infect Dis. 2023;10. doi:10.1093/ofid/ofad248.
   PubMed Web of Science ®Google Scholar
• Wei J, Pouwels KB, Stoesser N, Matthews PC, Diamond I, Studley R, Rourke E, Cook D, Bell JI, Newton JN. et al. Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines. Nat Med. 2022;28(5):1072–1082. doi:10.1038/s41591-022-01721-6.
   PubMed Web of Science ®Google Scholar
• Hwang YH, Song KH, Choi Y, Go S, Choi SJ, Jung J, Kang CK, Choe PG, Kim NJ, Park WB. et al. Can reactogenicity predict immunogenicity after COVID-19 vaccination? Korean J Intern Med. 2021;36(6):1486–1491. doi:10.3904/kjim.2021.210.
   PubMed Web of Science ®Google Scholar
• Zhang R, Leung KY, Liu D, Fan Y, Lu L, Chan PC, To KK, Chen H, Yuen KY, Chan KH. et al. Correlation of immunogenicity and reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 vaccines. mSphere. 2022;7(2):e0091521. doi:10.1128/msphere.00915-21.
   PubMed Web of Science ®Google Scholar
• Rau K, von Heeringen E, Bühler N, Wagenpfeil S, Becker SL, Schneitler S. Recipient-reported reactogenicity of different SARS-CoV-2 vaccination regimens among healthcare professionals and police staff in Germany. Vaccines. 2023;11(7):1147. doi:10.3390/vaccines11071147.
   Web of Science ®Google Scholar
• Feng S, Phillips DJ, White T, Sayal H, Aley PK, Bibi S, Dold C, Fuskova M, Gilbert SC, Hirsch I. et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 2021;27(11):2032–2040. doi:10.1038/s41591-021-01540-1.
   PubMed Web of Science ®Google Scholar